MMP9 and chronic obstructive pulmonary disease: Indeed, a placebo-controlled, AZD1236 biomarker study of 55 COPD patients again failed to demonstrate MMP-9 or MMP-12 inhibition in induced sputum [20], whereas we have demonstrated drug-target engagement of AZD1236 in humans.